Sources

5 Total Sources

GLP-1 Drugs Linked to 41% Lower Obesity-Cancer Risk in 229,000 Non-Diabetic Patients

Medical News Today18h ago

GLP-1 Medications Linked to 41% Drop in Obesity-Related Cancer Risk in Non-Diabetic Patients

Up to 14M Medicare patients could be eligible for GLP-1s for just $50 a month — here's who qualifies - AOL

Can GLP-1 drugs lower cancer risk in people with obesity? 📉 41% lower incidence of obesity-associated cancers with GLP-1RAs (HR 0.59, CI 0.53-0.67) 👥 approx 80k obese, nondiabetic adults, matched GLP-1RAs vs

Facebook18h ago

Yet another large database study is tying GLP-1 drugs to potential benefits in cancer, suggesting that some patients prescribed the medications after cancer diagnosis have a significantly decreased rate of progression to

Instagram18h ago

Durante años hablamos de obesidad, metabolismo y riesgo cardiovascular. Hoy, la conversación empieza a ir mucho más allá. Los agonistas de receptores GLP-1 están siendo estudiados en relación a la prevalencia y